Evidence map›Paper›PMID 40665385›Full record

ArticleVirology journal2025

Molecular characteristics of human adenovirus isolated from the 2024 influenza-like illness outbreaks in Suzhou City, China.

Jia Zang, Yueping Xing, Hongkai Zhang, Yanshi Wu, Xuerong Ya, Qiang Shen, Zefeng Dong

Abstract read
In one paragraph

Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jia Zang *Suzhou Center for Disease Control and Prevention, Suzhou, 215004, China.
Yueping Xing *Suzhou Center for Disease Control and Prevention, Suzhou, 215004, China.
Hongkai ZhangSuzhou Center for Disease Control and Prevention, Suzhou, 215004, China.
Yanshi WuSuzhou Center for Disease Control and Prevention, Suzhou, 215004, China.
Xuerong YaSuzhou Center for Disease Control and Prevention, Suzhou, 215004, China.
Qiang ShenSuzhou Center for Disease Control and Prevention, Suzhou, 215004, China. sqtom@126.com.
Zefeng DongSuzhou Center for Disease Control and Prevention, Suzhou, 215004, China. zefeng_dong@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman adenoviruses (HAdV) comprises a genetically diverse group of double-stranded DNA viruses strongly associated with influenza-like illness (ILI) and acute respiratory illnesses (ARI) outbreaks. This study aimed to elucidate the molecular characteristics of HAdV implicated during ILI outbreaks in Suzhou City, Jiangsu Province in 2024.

methodsThroat swab samples were gathered from settings with ILI outbreaks in Suzhou between March 2024 and January 2025. These samples were analyzed using rapid multi-pathogen detection and real-time PCR. HAdV-positive samples were inoculated into human epidermoid larynx carcinoma cell line (Hep2) for HAdV isolation, followed by whole-genome sequencing (WGS) using the MiSeq platform. Maximum likelihood (ML) phylogenetic trees for the whole genome, hexon, penton base and fiber genes were constructed using IQ-TREE v2.3.6 software. Amino acid variation analysis was performed with BioEdit 7.7.1 software, while recombination detection and visualization were conducted using Recombination Detection Program version 4.101 (RDP4) and SimPlot 3.5.1 software.

resultsOf 488 outbreak samples collected, 53 (10.86%) tested positive for HAdV, making it the second most prevalent respiratory pathogen. These HAdV-related respiratory outbreaks occurred during the spring-summer and autumn-winter transitions, showing no significant regional differences but a slightly higher positive rate in males than in females (13.83% vs. 7.66%, p = 0.028). Twenty-nine HAdV-positive samples were selected for viral isolation and genome sequencing. Phylogenetic analysis revealed that most isolates clustered with recently circulating HAdVB3 strains, while several clustered with HAdVB7 or previously reported HAdVB3/7 recombinant genotypes. Compared with the HAdVB3 reference sequence (OQ518322.1), multiple nonsynonymous amino acid substitutions were identified in antigenic determinant domains (loop 1 and loop 2) of the hexon protein. Besides, four substitution sites were detected in each of the penton base and fiber proteins. Recombination analysis identified seven strains as HAdVB3/7 recombinants, displaying three distinct recombination patterns. Notably, the strain SZTC20241129 carried HAdVB7-derived insertional fragments spanning partial E2B gene region, 52/55 kDa protein, protein IIIa precursor (pIIIa), and the penton base. In contrast, the other recombinant strains (SZZJ20240513, SZTC20241133, SZZJ20240515, SZZJ20240516, SZCS20241240 and SZCS20241242) possessed an HAdVB7-derived genomic backbone along with multiple HAdVB3-derived insertional fragments, encompassing a range of structural and regulatory genes.

conclusionsHAdV was one of the leading causative agents of ILI outbreaks in Suzhou in 2024, with HAdVB3 being the predominant genotype (22/29, 75.9%). Strikingly, HAdVB3/7 recombinant strains with P7H7F3 and P7H3F3 genetic constituents were also detected in a subset of cases (7/29, 24.1%). The genetic diversity of circulating HAdV continues to expand, driven by the emergence of novel amino acid substitutions and intertypic recombination events. These findings underscore the importance of sustained molecular surveillance to track viral evolution and inform effective public health strategies aimed at reducing the risk of severe clinical outcomes in vulnerable populations.

Indexed as

Adenoviruses, HumanAdenovirus Infections, HumanDisease OutbreaksAdolescentAdultAgedChildChild, PreschoolChinaFemaleGenetic VariationGenome, ViralHumansInfantMaleMiddle AgedGenome sequencingHuman adenovirusPhylogenetic analysisRecombinationVariation

Identifiers

PMID40665385
PMCPMC12265240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.